AVANOS MEDICAL UK LIMITED
Get an alert when AVANOS MEDICAL UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£6.6m
-2.6% lowest in 3 filed years
Net assets
£3.4m
+52% vs 2024
Employees
22
+15.8% highest in 3 filed years
Profit before tax
£1.5m
-29% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
Whilst the directors continue to believe that it is appropriate to prepare the financial statements on a going concern basis, the change in ultimate ownership gives rise to uncertainty regarding the intentions and future support of the new ultimate parent based on the updated strategic goals
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
-
Going-concern uncertainty disclosed
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £18,480,966 | £18,626,810 | £20,126,820 | +8.1% | |
| Operating profit | £800,452 | £1,853,054 | £1,238,048 | -33.2% | |
| Profit before tax | £1,120,756 | £2,166,600 | £1,538,655 | -29% | |
| Net profit | £869,317 | £1,607,985 | £1,147,628 | -28.6% | |
| Cash | £7,892,911 | £6,819,024 | £6,644,524 | -2.6% | |
| Total assets less current liabilities | £4,611,156 | £2,214,944 | £3,377,666 | +52.5% | |
| Net assets | £4,598,197 | £2,206,182 | £3,353,810 | +52% | |
| Equity | £4,598,197 | £2,206,182 | £3,353,810 | +52% | |
| Average employees | 20 | 19 | 22 | +15.8% | |
| Wages | £2,572,666 | £2,107,315 | £2,984,001 | +41.6% | |
| Directors' remuneration | — | £0 | £0 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 4.3% | 9.9% | 6.2% | |
| Net margin | 4.7% | 8.6% | 5.7% | |
| Return on capital employed | 17.4% | 83.7% | 36.7% | |
| Gearing (liabilities / total assets) | 58.0% | 77.6% | 74.4% | |
| Current ratio | 1.72x | 1.29x | 1.15x | |
| Interest cover | 70.39x | 31.80x | 8.66x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- AVANOS MEDICAL UK LIMITED 2019-02-05 → present
- HALYARD HEALTH UK LIMITED 2014-05-21 → 2019-02-05
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“Whilst the directors continue to believe that it is appropriate to prepare the financial statements on a going concern basis, the change in ultimate ownership gives rise to uncertainty regarding the intentions and future support of the new ultimate parent based on the updated strategic goals”
Significant events
- “On July 27, 2026, Avanos was acquired by affiliates of American Industrial Partners ('AIP'), a private equity firm.”
- “Avanos Medical Inc. announced on 2 April 2025, that it has taken direct responsibility for the sales and distribution of its MIC-KEY enteral feeding products in the United Kingdom, effective 25 July 2025.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 8 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KRINES, Dieter | Director | 2022-01-24 | Aug 1966 | German |
| VANDEROOST, Nancy Carine C | Director | 2018-04-06 | Nov 1967 | Belgian |
Show 8 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WOODS, Peter | Secretary | 2014-05-21 | 2014-10-16 |
| ALLSOP, James Cantle | Director | 2019-06-10 | 2021-11-21 |
| CASPAR, Thierry Charles-Andre | Director | 2018-04-06 | 2019-06-10 |
| DESCHAMPS, Pierre Gilles Yves | Director | 2014-05-21 | 2018-04-06 |
| DHILLON, Kalbander Singh | Director | 2014-05-21 | 2014-10-06 |
| MCPHERSON, Donna | Director | 2014-05-21 | 2014-10-06 |
| PRICE, Jonathan David | Director | 2014-10-06 | 2015-02-20 |
| VERREYDT, Bart | Director | 2014-10-06 | 2018-04-06 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dino Michael Cusumano | Individual | Significant influence | 2026-07-27 | Active |
| Justin Michael Richard Fish | Individual | Significant influence | 2026-07-27 | Active |
| Kim Adams Marvin | Individual | Significant influence | 2026-07-27 | Active |
| Avanos Medical, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2026-07-27 |
Filing timeline
Last 20 of 61 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-05-30 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-29 | AA | accounts | Accounts with accounts type full | |
| 2026-09-17 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-09-17 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-09-17 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-09-17 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-05-22 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-05-22 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-09-22 | AA | accounts | Accounts with accounts type full | |
| 2025-05-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-29 | AA | accounts | Accounts with accounts type full | |
| 2024-05-30 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2024-05-30 | CAP-SS | insolvency | Legacy | |
| 2024-05-30 | RESOLUTIONS | resolution | Resolution | |
| 2024-05-30 | SH20 | capital | Legacy | |
| 2024-05-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-25 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-10-06 | AA | accounts | Accounts with accounts type full | |
| 2023-06-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-24 | RP05 | address | Default companies house registered office address applied | |
| 2022-12-06 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.